764 related articles for article (PubMed ID: 26149228)
1. Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery.
Lee JY; Chung SJ; Cho HJ; Kim DD
Eur J Pharm Biopharm; 2015 Aug; 94():532-41. PubMed ID: 26149228
[TBL] [Abstract][Full Text] [Related]
2. Polyethylene glycol-conjugated chondroitin sulfate A derivative nanoparticles for tumor-targeted delivery of anticancer drugs.
Lee JY; Park JH; Lee JJ; Lee SY; Chung SJ; Cho HJ; Kim DD
Carbohydr Polym; 2016 Oct; 151():68-77. PubMed ID: 27474544
[TBL] [Abstract][Full Text] [Related]
3. Reduction-sensitive micelles self-assembled from amphiphilic chondroitin sulfate A-deoxycholic acid conjugate for triggered release of doxorubicin.
Liu H; Wu S; Yu J; Fan D; Ren J; Zhang L; Zhao J
Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():55-63. PubMed ID: 28415498
[TBL] [Abstract][Full Text] [Related]
4. Self-assembled nanoparticles based on chondroitin sulfate-deoxycholic acid conjugates for docetaxel delivery: Effect of degree of substitution of deoxycholic acid.
Liu M; Du H; Zhai G
Colloids Surf B Biointerfaces; 2016 Oct; 146():235-44. PubMed ID: 27343846
[TBL] [Abstract][Full Text] [Related]
5. Self-assembled nanoparticles of reduction-sensitive poly (lactic-co-glycolic acid)-conjugated chondroitin sulfate A for doxorubicin delivery: preparation, characterization and evaluation.
Wang XF; Ren J; He HQ; Liang L; Xie X; Li ZX; Zhao JG; Yu JM
Pharm Dev Technol; 2019 Jul; 24(6):794-802. PubMed ID: 30907676
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy.
Li W; Yi X; Liu X; Zhang Z; Fu Y; Gong T
J Control Release; 2016 Mar; 225():170-82. PubMed ID: 26826304
[TBL] [Abstract][Full Text] [Related]
7. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
[TBL] [Abstract][Full Text] [Related]
8. The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model.
Alibolandi M; Sadeghi F; Abnous K; Atyabi F; Ramezani M; Hadizadeh F
Eur J Pharm Biopharm; 2015 Aug; 94():521-31. PubMed ID: 26170161
[TBL] [Abstract][Full Text] [Related]
9. Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation.
Han X; Li Z; Sun J; Luo C; Li L; Liu Y; Du Y; Qiu S; Ai X; Wu C; Lian H; He Z
J Control Release; 2015 Jan; 197():29-40. PubMed ID: 25449802
[TBL] [Abstract][Full Text] [Related]
10. Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy.
Misra R; Sahoo SK
Eur J Pharm Sci; 2010 Jan; 39(1-3):152-63. PubMed ID: 19961929
[TBL] [Abstract][Full Text] [Related]
11. Angelica sinensis polysaccharide nanoparticles as a targeted drug delivery system for enhanced therapy of liver cancer.
Zhang Y; Cui Z; Mei H; Xu J; Zhou T; Cheng F; Wang K
Carbohydr Polym; 2019 Sep; 219():143-154. PubMed ID: 31151511
[TBL] [Abstract][Full Text] [Related]
12. Chondroitin sulfate-hybridized zein nanoparticles for tumor-targeted delivery of docetaxel.
Lee HS; Kang NW; Kim H; Kim DH; Chae JW; Lee W; Song GY; Cho CW; Kim DD; Lee JY
Carbohydr Polym; 2021 Feb; 253():117187. PubMed ID: 33278965
[TBL] [Abstract][Full Text] [Related]
13. Preparation and evaluation of reduction-responsive micelles based on disulfide-linked chondroitin sulfate A-tocopherol succinate for controlled antitumour drug release.
Cai S; Xie X; Yuan Q; Ding J; Meng L; Li J; He M; Li W; Yu J
J Pharm Pharmacol; 2021 Sep; 73(10):1405-1417. PubMed ID: 34254648
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin.
Mezghrani O; Tang Y; Ke X; Chen Y; Hu D; Tu J; Zhao L; Bourkaib N
Int J Pharm; 2015 Jan; 478(2):553-68. PubMed ID: 25455765
[TBL] [Abstract][Full Text] [Related]
15. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation.
Alibolandi M; Abnous K; Sadeghi F; Hosseinkhani H; Ramezani M; Hadizadeh F
Int J Pharm; 2016 Mar; 500(1-2):162-78. PubMed ID: 26802496
[TBL] [Abstract][Full Text] [Related]
16. A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: preparation, in vitro and in vivo evaluation.
Li Q; Lv S; Tang Z; Liu M; Zhang D; Yang Y; Chen X
Int J Pharm; 2014 Aug; 471(1-2):412-20. PubMed ID: 24905776
[TBL] [Abstract][Full Text] [Related]
17. Boronic acid-tethered amphiphilic hyaluronic acid derivative-based nanoassemblies for tumor targeting and penetration.
Jeong JY; Hong EH; Lee SY; Lee JY; Song JH; Ko SH; Shim JS; Choe S; Kim DD; Ko HJ; Cho HJ
Acta Biomater; 2017 Apr; 53():414-426. PubMed ID: 28216300
[TBL] [Abstract][Full Text] [Related]
18. Dual CD44 and folate receptor-targeted nanoparticles for cancer diagnosis and anticancer drug delivery.
Lee JY; Termsarasab U; Park JH; Lee SY; Ko SH; Shim JS; Chung SJ; Cho HJ; Kim DD
J Control Release; 2016 Aug; 236():38-46. PubMed ID: 27320169
[TBL] [Abstract][Full Text] [Related]
19. Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin.
Cho HJ; Yoon IS; Yoon HY; Koo H; Jin YJ; Ko SH; Shim JS; Kim K; Kwon IC; Kim DD
Biomaterials; 2012 Feb; 33(4):1190-200. PubMed ID: 22074664
[TBL] [Abstract][Full Text] [Related]
20. Targeted delivery of doxorubicin by CSA-binding nanoparticles for choriocarcinoma treatment.
Zhang B; Cheng G; Zheng M; Han J; Wang B; Li M; Chen J; Xiao T; Zhang J; Cai L; Li S; Fan X
Drug Deliv; 2018 Nov; 25(1):461-471. PubMed ID: 29426237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
